BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uys MM, Shahid M, Harvey BH. Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective. Front Psychiatry 2017;8:144. [PMID: 28855875 DOI: 10.3389/fpsyt.2017.00144] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Infantino R, Boccella S, Scuteri D, Perrone M, Ricciardi F, Vitale R, Bonsale R, Parente A, Allocca I, Virtuoso A, De Luca C, Belardo C, Amodeo P, Gentile V, Cirillo G, Bagetta G, Luongo L, Maione S, Guida F. 2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play. Biomedicine & Pharmacotherapy 2022;156:113844. [DOI: 10.1016/j.biopha.2022.113844] [Reference Citation Analysis]
2 Tekin N, Karamahmutoğlu TE, Aykaç A, Akakın D, Gören MZ. The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits. Pharmacology Biochemistry and Behavior 2022. [DOI: 10.1016/j.pbb.2022.173490] [Reference Citation Analysis]
3 Wang S, Haikarainen A, Pohjakallio A, Sipilä J, Kaskinoro J, Juhila S, Jalava N, Koskinen M, Vesajoki M, Kumpulainen E, Pystynen J, Koskelainen T, Holm P, Din Belle D. Development of Benzodioxine-heteroarylpiperazines as Highly Potent and Selective α2c Antagonists. Bioorg Med Chem Lett 2022;:129005. [PMID: 36174834 DOI: 10.1016/j.bmcl.2022.129005] [Reference Citation Analysis]
4 Alluri S, Eisenberg SM, Grisanti LA, Tanner M, Volkow ND, Kim SW, Kil K. Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114764] [Reference Citation Analysis]
5 de Bartolomeis A, Vellucci L, Barone A, Manchia M, De Luca V, Iasevoli F, Correll CU. Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacol Ther 2022;236:108236. [PMID: 35764175 DOI: 10.1016/j.pharmthera.2022.108236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Proudman RGW, Akinaga J, Baker JG. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors. Pharmacol Res Perspect 2022;10:e00936. [PMID: 35224877 DOI: 10.1002/prp2.936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res 2022;:106078. [PMID: 35026403 DOI: 10.1016/j.phrs.2022.106078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kikuchi T, Maeda K, Yamada S, Suzuki M, Hirose T, Futamura T, Mcquade RD. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_424] [Reference Citation Analysis]
9 Brocos-mosquera I, Miranda-azpiazu P, Muguruza C, Corzo-monje V, Morentin B, Meana JJ, Callado LF, Rivero G. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment. Transl Psychiatry 2021;11. [DOI: 10.1038/s41398-021-01762-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mncube K, Möller M, Harvey BH. Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression. Front Psychiatry 2021;12:688150. [PMID: 34867504 DOI: 10.3389/fpsyt.2021.688150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zeng F, Fan Y, Brown RW, Drew Gill W, Price JB, Jones TC, Zhu MY. Effects of Manipulation of Noradrenergic Activities on the Expression of Dopaminergic Phenotypes in Aged Rat Brains. ASN Neuro 2021;13:17590914211055064. [PMID: 34812056 DOI: 10.1177/17590914211055064] [Reference Citation Analysis]
12 Wu Y, Zeng L, Zhao S. Ligands of Adrenergic Receptors: A Structural Point of View. Biomolecules 2021;11:936. [PMID: 34202543 DOI: 10.3390/biom11070936] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
13 Brocos-Mosquera I, Gabilondo AM, Diez-Alarcia R, Muguruza C, Erdozain AM, Meana JJ, Callado LF. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects. Eur Neuropsychopharmacol 2021;52:3-11. [PMID: 34237656 DOI: 10.1016/j.euroneuro.2021.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kikuchi T, Maeda K, Suzuki M, Hirose T, Futamura T, McQuade RD. Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole. Neuropsychopharmacol Rep 2021;41:134-43. [PMID: 33960741 DOI: 10.1002/npr2.12180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Evdokimovskii EV, Jeon R, Park S, Pimenov OY, Alekseev AE. Role of α2-Adrenoceptor Subtypes in Suppression of L-Type Ca2+ Current in Mouse Cardiac Myocytes. Int J Mol Sci 2021;22:4135. [PMID: 33923625 DOI: 10.3390/ijms22084135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Patthy Á, Murai J, Hanics J, Pintér A, Zahola P, Hökfelt TGM, Harkany T, Alpár A. Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer's Disease. J Clin Med 2021;10:1555. [PMID: 33917176 DOI: 10.3390/jcm10081555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Rusu-Zota G, Burlui A, Rezus E, Paduraru L, Sorodoc V. Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats. Medicina (Kaunas) 2021;57:194. [PMID: 33668888 DOI: 10.3390/medicina57030194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Harvey BH, Uys MM, Viljoen FP, Shahid M, Sonntag Q, Meyer LCR. Hippocampal monoamine changes in the Flinders sensitive line rat: A case for the possible use of selective α2C-AR-antagonists in stress and anxiety disorders in companion animals. Res Vet Sci 2021;135:175-83. [PMID: 33529845 DOI: 10.1016/j.rvsc.2021.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother 2021;135:111200. [PMID: 33421734 DOI: 10.1016/j.biopha.2020.111200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 33.0] [Reference Citation Analysis]
20 Kikuchi T, Maeda K, Yamada S, Suzuki M, Hirose T, Futamura T, Mcquade RD. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole. NeuroPsychopharmacotherapy 2021. [DOI: 10.1007/978-3-319-56015-1_424-1] [Reference Citation Analysis]
21 Cong Z, Li D, Lv X, Yang C, Zhang Q, Wu C, Wang Z, Zhu X. α2A-adrenoceptor deficiency attenuates lipopolysaccharide-induced lung injury by increasing norepinephrine levels and inhibiting alveolar macrophage activation in acute respiratory distress syndrome. Clin Sci (Lond) 2020;134:1957-71. [PMID: 32643759 DOI: 10.1042/CS20200586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
22 Shahid M, Rinne JO, Scheinin M, Virta J, Marjamäki P, Solin O, Arponen E, Sallinen J, Kuokkanen K, Rouru J. Application of the PET ligand [11C]ORM-13070 to examine receptor occupancy by the α2C-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain. EJNMMI Res 2020;10:152. [PMID: 33296042 DOI: 10.1186/s13550-020-00741-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nachnani R, Raup-Konsavage WM, Vrana KE. The Pharmacological Case for Cannabigerol. J Pharmacol Exp Ther 2021;376:204-12. [PMID: 33168643 DOI: 10.1124/jpet.120.000340] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
24 Szechtman H, Harvey BH, Woody EZ, Hoffman KL. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap. Pharmacol Rev 2020;72:80-151. [PMID: 31826934 DOI: 10.1124/pr.119.017772] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
25 Li Z, Li J, Liu L, Deng W, Liu Q, Liu R, Zhang W, He Z, Fan L, Yang Y, Duan Y, Hou H, Wang X, Yang Z, Wang X, Chen S, Wang Y, Huang N, Chen J. Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor. Drug Des Devel Ther 2020;14:2585-94. [PMID: 32694911 DOI: 10.2147/DDDT.S214157] [Reference Citation Analysis]
26 Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, Mclean S, Grayson B, Idris N, Neill J, Sonesson C. (3 S )‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. J Pharmacol Exp Ther 2020;374:404-19. [DOI: 10.1124/jpet.120.000037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Gaidin SG, Zinchenko VP, Sergeev AI, Teplov IY, Mal'tseva VN, Kosenkov AM. Activation of alpha‐2 adrenergic receptors stimulates GABA release by astrocytes. Glia 2020;68:1114-30. [DOI: 10.1002/glia.23763] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
28 Boccella S, Iannotta M, Cristiano C, Iannotti FA, Bello FD, Guida F, Belardo C, Infantino R, Ricciardi F, Giannella M, Calignano A, Di Marzo V, Maione S, Luongo L. Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions. Front Pharmacol 2020;11:91. [PMID: 32161542 DOI: 10.3389/fphar.2020.00091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
29 Hamlett ED, Ledreux A, Gilmore A, Vazey EM, Aston-Jones G, Boger HA, Paredes D, Granholm AE. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiol Dis 2020;134:104616. [PMID: 31678403 DOI: 10.1016/j.nbd.2019.104616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Betti AH, Antonio CB, Herzfeldt V, Pitta MGDR, da Rocha Pitta I, do Rego J, do Rego J, Vaudry D, Rates SMK. PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice. Behavioural Pharmacology 2019;30:574-87. [DOI: 10.1097/fbp.0000000000000494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Li Z, Li J, Liu L, Deng W, Zhang W, Hou H, Wang X, Yang Z, Wang X, Chen S, Wang Y, Chen J, Huang N. Structural insight into the mechanism of 4-aminoquinolines selectivity for the alpha2A-adrenoceptor.. [DOI: 10.1101/561894] [Reference Citation Analysis]
32 Alekseev AE, Park S, Pimenov OY, Reyes S, Terzic A. Sarcolemmal α2-adrenoceptors in feedback control of myocardial response to sympathetic challenge. Pharmacol Ther 2019;197:179-90. [PMID: 30703415 DOI: 10.1016/j.pharmthera.2019.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Ma Q, Yang X, Lei X, Lin G. A highly enantioselective synthetic method towards the α2c-adrenoceptor antagonist ORM-10921. Org Chem Front 2019;6:773-779. [DOI: 10.1039/c8qo01166d] [Reference Citation Analysis]
34 Shimokawa T, Tsutsui H, Miura T, Takama M, Hayashi K, Nishinaka T, Terada T, Yoneda K, Yamagata M, Yukimura T. Post-treatment with JP-1302 protects against renal ischemia/reperfusion-induced acute kidney injury in rats. J Pharmacol Sci 2019;139:137-42. [PMID: 30665845 DOI: 10.1016/j.jphs.2018.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Savolainen K, Ihalainen J, Jalkanen AJ, Forsberg MM. Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats. Psychopharmacology (Berl) 2019;236:1245-53. [PMID: 30535904 DOI: 10.1007/s00213-018-5130-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Erdozain AM, Brocos-mosquera I, Gabilondo AM, Meana JJ, Callado LF. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex. J Psychopharmacol 2019;33:244-9. [DOI: 10.1177/0269881118798612] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
37 Abrahamson D, Flood VJ, Miele JA, Siu Y. Enactivism and ethnomethodological conversation analysis as tools for expanding Universal Design for Learning: the case of visually impaired mathematics students. ZDM Mathematics Education 2019;51:291-303. [DOI: 10.1007/s11858-018-0998-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
38 Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther 2018;192:20-41. [PMID: 29953902 DOI: 10.1016/j.pharmthera.2018.06.012] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 23.0] [Reference Citation Analysis]
39 Swanepoel T, Möller M, Harvey BH. N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges. Psychopharmacology 2018;235:351-68. [DOI: 10.1007/s00213-017-4776-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
40 Russell VA. Notes on the Recent History of Neuroscience in Africa. Front Neuroanat 2017;11:96. [PMID: 29163069 DOI: 10.3389/fnana.2017.00096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]